Immunology of age-related macular degeneration
J Ambati, JP Atkinson, BD Gelfand - Nature Reviews Immunology, 2013 - nature.com
Age-related macular degeneration (AMD) is a leading cause of blindness in aged
individuals. Recent advances have highlighted the essential role of immune processes in …
individuals. Recent advances have highlighted the essential role of immune processes in …
Inflammatory mechanisms of age-related macular degeneration
Late age-related macular degeneration (AMD), specifically central geographic atrophy (GA)
and choroidal neovascularization (CNV), 1 is the leading cause of irreversible vision loss in …
and choroidal neovascularization (CNV), 1 is the leading cause of irreversible vision loss in …
Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration
I Krebs, C Glittenberg, S Ansari-Shahrezaei… - British Journal of …, 2013 - bjo.bmj.com
Purpose Most of the publications on modern therapy of neovascular age-related macular
degeneration focus on the effect of the treatment. The purpose of this study is to determine …
degeneration focus on the effect of the treatment. The purpose of this study is to determine …
Dexamethasone intravitreal implant as adjunctive therapy to ranibizumab in neovascular age-related macular degeneration: a multicenter randomized controlled trial
BD Kuppermann, M Goldstein, RK Maturi, A Pollack… - …, 2015 - karger.com
Purpose: To evaluate the efficacy and safety of dexamethasone intravitreal implant 0.7 mg
(DEX) as adjunctive therapy to ranibizumab in neovascular age-related macular …
(DEX) as adjunctive therapy to ranibizumab in neovascular age-related macular …
Corticosteroids: triamcinolone, dexamethasone and fluocinolone
J Cáceres-del-Carpio, RD Costa, A Haider… - Retinal …, 2016 - karger.com
Steroids have been extensively used to treat macular edema due to diabetic retinopathy,
venous occlusive disease, ocular inflammation and, to a lesser extent, also in some cases of …
venous occlusive disease, ocular inflammation and, to a lesser extent, also in some cases of …
Intraocular concentrations of cytokines and chemokines in rhegmatogenous retinal detachment and the effect of intravitreal triamcinolone acetonide
H Kunikata, M Yasuda, N Aizawa, Y Tanaka… - American journal of …, 2013 - Elsevier
PURPOSE: To investigate the role of intravitreal injection of triamcinolone acetonide (IVTA)
in preventing photoreceptor apoptosis in eyes with rhegmatogenous retinal detachment …
in preventing photoreceptor apoptosis in eyes with rhegmatogenous retinal detachment …
Analyzing relative blood flow speeds in choroidal neovascularization using variable interscan time analysis OCT angiography
Purpose Longitudinally visualizing relative blood flow speeds within choroidal
neovascularization (CNV) may provide valuable information regarding the evolution of CNV …
neovascularization (CNV) may provide valuable information regarding the evolution of CNV …
Ocular and systemic safety of bevacizumab and ranibizumab in patients with neovascular age-related macular degeneration
D Johnson, S Sharma - Current Opinion in Ophthalmology, 2013 - journals.lww.com
Ocular and systemic safety of bevacizumab and ranibizumab in... : Current Opinion in
Ophthalmology Ocular and systemic safety of bevacizumab and ranibizumab in patients with …
Ophthalmology Ocular and systemic safety of bevacizumab and ranibizumab in patients with …
Simultaneous dexamethasone intravitreal implant and anti-VEGF therapy for neovascular age-related macular degeneration resistant to anti-VEGF monotherapy
Purpose: To evaluate the efficacy of a dexamethasone intravitreal implant in combination
with intravitreal anti-vascular endothelial growth factor (VEGF) agents for treatment-resistant …
with intravitreal anti-vascular endothelial growth factor (VEGF) agents for treatment-resistant …
Simultaneous Intravitreal Steroid and Anti-VEGF Therapy for Monotherapy-Resistant Chronic Wet Age-Related Macular Degeneration
Background and Objective The purpose of this study was to analyze the safety and efficacy
of combined intravitreal anti-vascular endothelial growth factor (anti-VEGF) and steroid …
of combined intravitreal anti-vascular endothelial growth factor (anti-VEGF) and steroid …